Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CBPO, PWRM, CJJD, KH - Stock Alerts! from - China Biologic Products , Power3 Medical Products, China Jo-Jo Drugstores, China Kanghui Holdings

|Includes:China Biologic Products, Inc. (CBPO)







  Power3 Medical Products, Inc. (OTC:PWRM)

PWRM, a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced earlier this month that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease in Honolulu, Hawaii. These presentations discussed NuroPro, PWRM's diagnostic test, and focused on PWRM's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

PWRM has filed several patent applications for its NuroPro technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.

PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM's products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease. PWRM's products analyze proteins and their mutations to assess an individual's risk for developing disease later in life or a patient's likelihood of responding to a particular drug; assess a patient's risk of disease progression and disease recurrence; and measure a patient's exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.

To learn more about PWRM visit:


China Biologic Products, Inc. (Nasdaq:CBPO)

CBPO, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., recently reported financial results for its second quarter ended June 30, 2010.

CBPO, a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. CBPO sells its products primarily to hospitals and inoculation centers through distributors. CBPO was founded in 1971 and is based in Taian City, the People's Republic of China.

To learn more about CBPO visit:


China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD)

CJJD, which operates a retail pharmacy chain in Zhejiang Province, recently announced additional store openings in Hangzhou, increasing Jo-Jo Drugstores’ total store count to 45 locations. Four additional locations are planned to be opened by October 2010.

“We are continuing to execute on our plan to have 60 locations in Zhejiang Province by March 2011,” stated Dr. Lei Liu, Chairman and CEO of CJJD. “The opening of these stores continues to strengthen our market position.”

CJJD owns and operates a retail pharmacy chain in the People's Republic of China. CJJD's stores sell various medicinal products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine products, personal care products, family care products, and medical devices, as well as convenience products including consumable, seasonal, and promotional items. CJJD also provides traditional and western medical services; and medical-related management consulting services. CJJD operates approximately 42 stores in the Zhejiang Province. CJJD is headquartered in Hangzhou, the People's Republic of China.

To learn more about CJJD visit:


China Kanghui Holdings (NYSE:KH)

KH, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, recenlty announced that its initial public offering of 6,675,000 American Depositary Shares, representing 40,050,000 ordinary shares, was priced at $10.25 per ADS. KH is offering 5,340,000 ADS's, and the selling shareholders are offering 1,335,000 ADSs. The ADS's are expected to begin trading on the New York Stock Exchange on August 11, 2010.

KH develops, manufactures, and markets orthopedic implants and associated instruments. KH offers approximately 30 product series of orthopedic implants and associated instruments for trauma, spine, cranial maxillofacial, and craniocerebral indications. KH was founded in 1996 and is headquartered in Changzhou, the People's Republic of China.

To learn more about KH visit:





Signup for FREE Daily Stock Alerts From 


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received five hundred thousand shares as compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (OTC:PWRM). Recently, Crown Equity Holdings Inc. had received an additional amount of 2,000,000 shares of free trading stock for 60 days of media advertisement, web design and maintenance for Power 3 Medical Products Inc. (OTC:PWRM). Each advertising commitment has now expired.

Stocks: CBPO